Novo Nordisk ends Wegovy sales on Hims & Hers over "deceptive marketing"
Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.
Watch CBS News
Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a rule the Biden administration has proposed.
Record demand for Ozempic, Wegovy and other weight loss drugs is fueling a surge of dangerous knockoffs.
Drugs like Mounjaro and Ozempic, which many use for weight loss, may also help patients suffering from addiction, according to a new study.
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the meantime, a market for cheaper, compounded drugs thrives.
Do weight loss drug labels warn enough about potential side effects? A patient who needed emergency surgery is suing prescription drugmaker Novo Nordisk.
Semaglutide, the active ingredient in drugs like Wegovy and Ozempic, can help people lose weight — and a new study says it may also help people quit smoking.
Michigan's largest insurance company said it will begin eliminating coverage of various weight loss drugs next year.
Members of the warehouse club can now sign up for a service that offers access to drugs like Ozempic.
GLP-1 class medications reduce cardiovascular risk and treat diabetes. But they also allow people to lose an average of 10-20 percent of their body weight in the first year. What does that mean for the overweight or obese?
Ozempic and other GLP-1 RA drugs, including Wegovy, Mounjaro and Zepbound, are being scrutinized.
From the Ozempic "ripple effect" to health tech and more, experts share their predictions for 2024 wellness trends.
The FDA and drugmaker Novo Nordisk are working to identify thousands of counterfeit Ozempic drugs seized in an ongoing investigation.
The medication, tirzepatide, was previously approved as Mounjaro for diabetes and will now be marketed as Zepbound for weight loss.
It is unclear if the counterfeit drugs, which many people seek for weight loss, caused the hospitalizations.
The warning about scams comes as sales have boomed for Ozempic, Wegovy and other drugs used for weight loss.
The FDA stopped short of saying the potentially life-threatening condition was caused by the drugs, which have become popular for weight loss.
While Ozempic's interaction with the reward centers in our brain could help explain this, Dr. Tamika Henry, founder of Unlimited Health Institute, says more studies are needed.
